By using a ready-to-use strip, researchers can reduce preparation-related variability while maintaining experimental control throughout extended study timelines
A typical transitional protocol might involve four weeks at 0.25 mg daily, followed by two weeks at 0.15 mg daily, then maintenance at 0.1 mg daily for extended periods
Trial monitoring of the conduct of the trial and data management was performed by Ozmosis
Results indicated that the type-2 diabetes, on semaglutide group exhibited more advanced disease progression, as reflected by a greater number of diabetes medication classes, a more comorbidities, and a higher cardiovascular medication burden (see Supplemental Information Section 4 for further information)
GLP-1 also supports blood sugar control
GIP receptors exist throughout the body, including in the developing digestive system